Biosurgery is a medical procedure that utilizes various natural as well as synthetic components in order to offer advanced surgery care. Various products used for the purpose of biosurgery include, bone graft substitutes, soft tissue attachments, surgical sealants & adhesives, adhesion barriers, and hemostatic agents. These products can be natural as well as artificial in nature and are used as per the medical needs that vary according to the applications.

Rising geriatric population and increasing volume of surgeries and prevalence of severe trauma injuries are expected to fuel the growth of the biosurgery market during the forecast period. Moreover, the rising demand for better healthcare facilities in emerging nations is anticipated to offer growth opportunities to the companies in the market.

The "Global Biosurgery Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, end user, and geography. The global market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading biosurgery market players and offers key trends and opportunities in the market.

The global biosurgery market is segmented on the basis of product and application. Based on product, the market is classified as, bone graft substitutes, soft tissue attachments, surgical sealants & adhesives, adhesion barriers, and hemostatic agents. The biosurgery market is categorized based on application as, orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, gynecological surgery, and other applications.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global biosurgery market based on product and application. It also provides market size and forecast till 2028 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biosurgery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the biosurgery market in the coming years, owing to advanced healthcare facilities as well as easy access to better services. Asia Pacific is anticipated to witness significant growth in the market during the forecast period, due to rise in the geriatric population in major economies such as, China, Japan and India.

The report analyzes factors affecting biosurgery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biosurgery market in these regions.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the biosurgery market include B. Braun Melsungen AG, Baxter, BD, CryoLife, Inc., Ethicon US, LLC., Integra LifeSciences, Ocular Therapeutix, Inc., SIRAKOSS, Stryker, and Vivostat A/S among others.